OptimizeRx Set to Join S&P SmallCap 600

Rhea-AI Summary

OptimizeRx Corp. (NASDAQ: OPRX) is set to replace Lydall Inc. (NYSE: LDL) in the S&P SmallCap 600 index effective October 4, 2021. This change is occurring as Clearlake Capital Group is acquiring Lydall, with the deal expected to close around October 1. This addition marks a significant milestone for OptimizeRx, aligning it with a key financial benchmark, while Lydall will be removed from the index.

Positive

• OptimizeRx's inclusion in the S&P SmallCap 600 enhances its visibility and could attract more investment.
• The transition reflects positive market recognition for OptimizeRx's growth potential.

Negative

• The removal of Lydall from the index may indicate broader market skepticism about its financial health post-acquisition.

NEW YORK, Sept. 29, 2021 /PRNewswire/ -- OptimizeRx Corp. (NASD:OPRX) will replace Lydall Inc. (NYSE:LDL) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, October 4. Clearlake Capital Group is acquiring Lydall in a deal that is expected to close on or about October 1.

Following is a summary of the changes that will take place prior to the open of trading on the effective date:

Effective Date	Index Name	Action	Company Name	Ticker	GICS Sector
October 4, 2021	S&P SmallCap 600	Addition	OptimizeRx	OPRX	Health Care
	S&P SmallCap 600	Deletion	Lydall	LDL	Industrials

For more information about S&P Dow Jones Indices, please visit www.spdji.com

ABOUT S&P DOW JONES INDICES

S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.

FOR MORE INFORMATION:

S&P Dow Jones Indices
index_services@spglobal.com

Media Inquiries
spdji.comms@spglobal.com

View original content:https://www.prnewswire.com/news-releases/optimizerx-set-to-join-sp-smallcap-600-301388316.html

SOURCE S&P Dow Jones Indices

FAQ

When is OptimizeRx joining the S&P SmallCap 600?

OptimizeRx will join the S&P SmallCap 600 effective October 4, 2021.

What will happen to Lydall in the S&P SmallCap 600?

Lydall will be removed from the S&P SmallCap 600 effective October 4, 2021.

What is the significance of OptimizeRx's inclusion in the S&P SmallCap 600?

The inclusion could enhance OptimizeRx's visibility and attract more institutional investors.

Who is acquiring Lydall?

Lydall is being acquired by Clearlake Capital Group, with the deal expected to close around October 1, 2021.

What are the ticker symbols involved in this press release?

The ticker symbols are OPRX for OptimizeRx and LDL for Lydall.